JENNIFER WADE: Open Payments
NPI 1053736231 · MECHANICSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,004 in 94 payments from 18 companies in 2025. Trend: 2023 $2,025 · 2024 $2,084 · 2025 $2,004
Food & beverage: $2,004
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $644 |
| Novartis Pharmaceuticals Corporation | 13 | $210 |
| Biogen, Inc. | 9 | $183 |
| Teva Pharmaceuticals USA, Inc. | 6 | $155 |
| Eisai Inc. | 6 | $128 |
| Vanda Pharmaceuticals Inc. | 4 | $90 |
| Celgene Corporation | 3 | $65 |
| Neurocrine BioSciences, Inc. | 3 | $65 |
| Lilly USA, LLC | 3 | $62 |
| Lundbeck LLC | 3 | $60 |
Products named: QULIPTA, BOTOX, KESIMPTA, Leqembi, TYSABRI, AUSTEDO XR, UBRELVY, PONVORY.
Industry payments across MD — which companies pay providers there.
